Most Recent
Publisher HarperCollins has filed a special leave application with the High Court seeking to challenge a decision that revived a defamation case by a psychiatrist over a book covering the controversial deep sleep therapy at the Chelmsford Private Hospital in the 1970s.
German pharmaceutical giant Bayer, which is facing a legal bid by generic drug maker Sandoz to invalidate patents covering blood clot drug Xarelto, is seeking to amend one of the patents in dispute.
US medical device maker Boston Scientific has agreed to pay $105 million to settle a class action on behalf of Australian women implanted with one or more of the company's pelvic mesh or sling products.
A judge has dismissed a proceeding against the New South Wales government over a mandate requiring healthcare workers to be vaccinated against COVID-19, saying the applicant’s constitutional case was “legally misconceived and must be rejected.”
Korean drug company Samsung Bioepis has filed a second lawsuit seeking to invalidate German drug company Fresenius Kadi's patent for a biosimilar of blockbuster arthritis drug Humira.
A former Sigma Healthcare executive has been sentenced to a suspended term of 14 months' in prison after pleading guilty to trading on insider information.
A class action investigation is underway against Cosmos Clinics Australia after an investigative report by Fairfax uncovered what it said was a "litany of troubling practices" at its clinics around Australia.
A judge has dismissed a case seeking to force Nine to hand over draft versions of a 60 Minutes episode and related stories, after an appeals court threw out orders that would have forced production of the material.
Nine has won its legal challenge to orders that would have forced it to hand over a draft version of a 60 Minutes episode and restricted it from airing the program after an appeals court found a judge had no power to make the orders.
Regenerative medicine company Mesoblast has been hit with a second class action for allegedly misleading shareholders about it Remestemcel-L treatment for COVID-19 complications.